Are Laurus Labs Ltd latest results good or bad?

2 hours ago
share
Share Via
Laurus Labs Ltd's latest results are generally positive, showing strong growth in net profit and revenue for Q4 FY26, with a net profit of ₹279.14 crores and a revenue increase of 5.31%. However, recent quarterly data indicates a slowdown in growth rates, suggesting a need for careful monitoring of sustainability moving forward.
Laurus Labs Ltd has reported its financial results for the quarter ended March 2026, showcasing a strong operational performance characterized by significant growth in net profit and revenue. The net profit for Q4 FY26 reached ₹279.14 crores, reflecting a year-on-year growth of 19.46%. Revenue for the same quarter stood at ₹1,811.57 crores, marking a 5.31% increase compared to the previous year. The operating margin, excluding other income, expanded to 28.27%, a notable improvement from the prior year, indicating effective cost management and a favorable product mix.
The full-year results for FY26 highlight a substantial recovery, with consolidated net profit reaching ₹888.79 crores, a dramatic turnaround from ₹233.67 crores in FY25. This recovery underscores Laurus Labs' successful navigation through previous challenges, with consistent quarterly improvements observed throughout FY26. In the latest quarter, the company demonstrated operational excellence with an operating profit before depreciation, interest, and tax (excluding other income) of ₹512.11 crores, which reflects a 21.77% increase year-on-year. The gross profit margin also improved to 26.69%, driven by better manufacturing efficiencies and pricing dynamics. However, the latest data for the quarter ended June 2026 indicates a slowdown in growth rates, with net sales increasing by 29.10% year-on-year compared to a higher growth rate of 31.35% in the same quarter of the previous year. Similarly, the consolidated net profit growth of 125.49% in June 2026 is a significant decline from the extraordinary growth of 1,203.12% reported in June 2025. Overall, Laurus Labs has seen an adjustment in its evaluation, reflecting the company's operational strengths and recent performance trends. The financial results indicate a solid recovery trajectory, although the recent quarterly data suggests a need for careful monitoring of growth sustainability moving forward.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News